FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

Published:2010-12-21 Issue:2 Volume:108 Page:751-756
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Choi J. W.,Gardell S. E.,Herr D. R.,Rivera R.,Lee C.-W.,Noguchi K.,Teo S. T.,Yung Y. C.,Lu M.,Kennedy G.,Chun J.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference47 articles.

1. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System

2. Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

3. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

4. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

5. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Cited by 531 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting sphingosine 1-phosphate lyase: From efficacy to mechanism;Neurobiology of Disease;2024-09

2. Lysophospholipid receptors in neurodegeneration and neuroprotection;Exploration of Neuroprotective Therapy;2024-08-22

3. The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function;Frontiers in Pharmacology;2024-08-19

4. Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature;Cardiovascular Research;2024-08-01

5. S1P/S1PR1 signaling is involved in the development of nociceptive pain;Frontiers in Pharmacology;2024-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3